Press Releases
November 21, 2019 at 8:00 AM EST
Altimmune to Host Key Opinion Leader Call on ALT-801 for the Treatment of NASH
November 13, 2019 at 4:15 PM EST
Altimmune Announces Third Quarter 2019 Financial Results and Provides a Business Update
November 6, 2019 at 7:00 AM EST
Altimmune to Announce Third Quarter 2019 Financial Results on November 14
October 10, 2019 at 7:00 AM EDT
Altimmune to Participate in Upcoming Investor Conferences
September 9, 2019 at 7:00 AM EDT
Altimmune Appoints M. Scott Harris, M.D. as Chief Medical Officer
August 21, 2019 at 7:00 AM EDT
Altimmune Announces $3.7 Million in Additional BARDA Funding to Advance NasoShield™ Clinical Development
August 13, 2019 at 4:15 PM EDT
Altimmune Announces Second Quarter 2019 Financial Results and Provides a Business Update
August 5, 2019 at 7:00 AM EDT
Altimmune to Announce Second Quarter 2019 Financial Results on August 14
July 15, 2019 at 7:00 AM EDT
Altimmune Announces Closing of Acquisition of Spitfire Pharma, Inc.
July 9, 2019 at 7:00 AM EDT
Altimmune Signs Definitive Agreement to Acquire Spitfire Pharma, Inc. Adding NASH Drug Candidate to Portfolio
Displaying 1 - 10 of 23